Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 

Leukaemia survival statistics

One-, five- and ten-year survival statistics for leukaemia (all subtypes combined) by age and trends over time are presented here.

Find out more about the counting and coding of this data.

 

One-, five- and ten-year survival

71% of men survive leukaemia (all subtypes combined) for at least one year, and this is predicted to fall to 54% surviving for five years or more, as shown by age-standardised net survival for patients diagnosed with leukaemia during 2010-2011 in England and Wales (Table 3.1).1 Survival for women is slightly lower, with 66% surviving for one year or more, and 49% predicted to survive for at least five years.

Table 3.1: Leukaemia (C91-C95), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 2010-2011

1-Year Survival (%) 5-Year Survival (%) 10-Year Survival (%)
Men Net Survival 70.9 53.5 47.5
95% LCL 70.9 53.2 46.9
95% UCL 71.0 53.7 48.1
Women Net Survival 66.0 49.2 44.4
95% LCL 65.9 48.8 43.6
95% UCL 66.2 49.6 45.2
Adults Net Survival 68.8 51.6 46.2
95% LCL 68.7 51.4 45.7
95% UCL 68.8 51.8 46.6

Download this table XLS (32KB) PPT (138KB) PDF (26KB)

95% LCL and 95% UCL are the 95% lower and upper confidence limits
Five- and ten-year survival is predicted using an excess hazard statistical model

Leukaemia survival gradually continues to fall beyond five years after diagnosis. 48% of men and 44% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with leukaemia during 2010-2011 in England and Wales (Figure 3.1).1 Out of 20 common cancers in England and Wales, ten-year survival for leukaemia ranks 8th lowest overall.

Figure 3.1: Leukaemia (C91-C95), Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales, 2010-2011

surv_curve_leukaemia.swf

Download this chart XLS (45KB) PPT (126KB) PDF (72KB)

Survival for leukaemia is reported in Scotland and Northern Ireland,2,3 though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses.

section reviewed 28/11/14
section updated 28/11/14

 

By age

Five-year survival for leukaemia (all subtypes combined) is generally higher in younger men and women, peaking at age 40-49 and decreasing with increasing age. Five-year net survival in men ranges from 67% in 15-39 year-olds to 23% in 80-99 year-olds for patients diagnosed with leukaemia in England during 2007-2011 (Figure 3.2).4 In women, five-year survival ranges from 68% to 23% in the same age groups.

Figure 3.2: Leukaemia (C91-C95), Five-Year Net Survival by Age, England, 2007-2011

surv_5yr_age_leukaemia.swf

Download this chart XLS (43KB) PPT (124KB) PDF (44KB)

section reviewed 28/11/14
section updated 28/11/14

 

Trends over time

As with most cancers, survival for leukaemia is improving. Some of the increase is likely to be attributable to changes in the diagnosis, classification and registration of leukaemia, so interpretation of these trends should be undertaken with caution.

One-year age-standardised net survival for leukaemia (all subtypes combined) in men has increased from 35% during 1971-1972 to 71% during 2010-2011 in England and Wales – an absolute survival difference of 36 percentage points (Figure 3.3).1 In women, one-year survival has increased from 33% to 66% over the same time period (a difference of 34 percentage points).

Figure 3.3: Leukaemia (C91-C95), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

surv_1yr_leukaemia.swf

Download this chart XLS (46KB) PPT (127KB) PDF (54KB)

Five-year age-standardised net survival for leukaemia in men has increased from 13% during 1971-1972 to a predicted survival of 54% during 2010-2011 in England and Wales – an absolute survival difference of 41 percentage points (Figure 3.4).1 In women, five-year survival has increased from 13% to 49% over the same time period (a difference of 36 percentage points).

Figure 3.4: Leukaemia (C91-C95), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

surv_5yr_leukaemia.swf

Download this chart XLS (46KB) PPT (126KB) PDF (54KB)

Five-year survival for 2010-2011 is predicted using an excess hazard statistical model

Ten-year survival has followed the same trend as one- and five-year survival since the early 1970s. Ten-year age-standardised net survival for leukaemia in men has increased from 7% during 1971-1972 to a predicted survival of 48% during 2010-2011 in England and Wales – an absolute survival difference of 41 percentage points (Figure 3.5).1 In women, ten-year survival has increased from 7% to 44% over the same time period (a difference of 37 percentage points). Overall, more than 4 in 10 people diagnosed with leukaemia today are predicted to survive their disease for at least ten years.

Figure 3.5: Leukaemia (C91-C95), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

surv_10yr_leukaemia.swf

Download this chart XLS (46KB) PPT (126KB) PDF (54KB)

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model

section reviewed 28/11/14
section updated 28/11/14

No Error

Rate this page:
Submit rating
Rated 5 out of 5 based on 3 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

Visit our A-Z topic pages

 

References for leukaemia mortality

  1. Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine. Personal communication, 2014.
  2. ISD Scotland. Trends in Cancer Survival 1983-2007.
  3. Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.
  4. Office for National Statistics. Statistical Bulletin: Cancer survival in England: Patients diagnosed 2007-2011 and followed up to 2012. Newport: ONS; 2013.
Updated: 28 November 2014